• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撤回:纳米颗粒在多囊卵巢综合征管理中的应用

WITHDRAWN: Application of Nanoparticles in the Management of Polycystic Ovary Syndrome.

作者信息

Al-Hetty Hussein Riyadh Abdul Kareem, Saleh Marwan Mahmood, Jalil Abduladheem Turki

机构信息

Department of Medical Laboratories Techniques, Al-Mustaqbal University College, Hillah, Babylon, Iraq.

Department of Medical Laboratory Technology, College of Medical Technology, The Islamic University, Najaf, Iraq.

出版信息

Curr Drug Res Rev. 2023 Aug 17. doi: 10.2174/2589977515666230817121135.

DOI:10.2174/2589977515666230817121135
PMID:37592786
Abstract

UNLABELLED

The article has been withdrawn at the request of the Corresponding author. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php.

BENTHAM SCIENCE DISCLAIMER

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

摘要

未标注

应通讯作者要求,本文已撤回。本瑟姆科学出版社就由此可能给期刊读者带来的不便深表歉意。关于文章撤回的本瑟姆编辑政策可在https://benthamscience.com/editorial-policies-main.php查询。

本瑟姆科学出版社免责声明

提交至本期刊的稿件未曾发表且不会同时提交至其他地方发表或在其他地方发表,这是发表的条件。此外,任何已在其他地方发表的数据、插图、结构或表格都必须报告,并必须获得复制的版权许可。严禁抄袭,提交文章以供发表即表示作者同意,如果发现抄袭或虚假信息,出版商有权对作者采取适当行动。提交稿件即表示作者同意,如果文章被接受发表,其文章版权将转让给出版商。

相似文献

1
WITHDRAWN: Application of Nanoparticles in the Management of Polycystic Ovary Syndrome.撤回:纳米颗粒在多囊卵巢综合征管理中的应用
Curr Drug Res Rev. 2023 Aug 17. doi: 10.2174/2589977515666230817121135.
2
WITHDRAWN: Covid-19 Study, Pathology and Therapeutics.撤回:新冠病毒-19研究,病理学与治疗学。
Infect Disord Drug Targets. 2022 Feb 15. doi: 10.2174/1871526522666220215114012.
3
WITHDRAWN: Original Antigenic Sin in COVID-19: Hoskins Effect and Vaccine.撤回:新冠病毒中的原始抗原性原罪:霍斯金斯效应与疫苗
Infect Disord Drug Targets. 2022 Mar 17. doi: 10.2174/1871526522666220317154549.
4
WITHDRAWN: Rap2A/p-ERK1/2 is Involved in Glioma Proliferation and Migration.撤回:Rap2A/p-ERK1/2参与胶质瘤的增殖和迁移。
Curr Mol Med. 2022 Aug 4. doi: 10.2174/1566524022666220804152049.
5
Withdrawn: Camel FGF21 Protein Enhances FGF21 Signaling and its Targeted Compounds Screening.撤回:骆驼FGF21蛋白增强FGF21信号传导及其靶向化合物筛选
Curr Pharm Des. 2024 Sep 30. doi: 10.2174/0113816128332755240912041051.
6
Withdrawal Notice: Applying Peer Mentoring to Improve Learning Human Anatomy.
Cent Nerv Syst Agents Med Chem. 2021 Feb 11. doi: 10.2174/1871524921666210212110151.
7
WITHDRAWN: Long-time-released Transdermal Microneedle Delivery System.撤回:长效释放透皮微针给药系统。
Curr Drug Deliv. 2023 Nov 23. doi: 10.2174/0115672018266536231107053636.
8
WITHDRAWN: Pharmaceutical Nanoemulsion System: A Strategy to Enhance the Bioavailability of Drugs.撤回:药物纳米乳剂系统:提高药物生物利用度的一种策略。
Curr Drug Metab. 2022 Jun 30. doi: 10.2174/1389200223666220630161615.
9
WITHDRAWN: The Ascension of Nanosponges as a Drug Delivery Carrier: Preparation, Characterization and Applications.撤回:纳米海绵作为药物递送载体的崛起:制备、表征及应用
Curr Drug Deliv. 2022 Jun 16. doi: 10.2174/1567201819666220616120828.
10
Withdrawal Notice: Atrial Fibrillation and Hypertension: “Quo Vadis”.撤稿通知:心房颤动与高血压:“何去何从”
Curr Hypertens Rev. 2019 May 2. doi: 10.2174/1573402115666190502142824.